Clonorchis sinensis-Derived Protein Attenuates Inflammation and New Bone Formation in Ankylosing Spondylitis (2021)
https://pubmed.ncbi.nlm.nih.gov/33717104/

STAT3 phosphorylation inhibition for treating inflammation and new bone formation in ankylosing spondylitis (2021)
https://pubmed.ncbi.nlm.nih.gov/33237331/

Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study (2021)
https://pubmed.ncbi.nlm.nih.gov/33462157/

Radiographic Progression in Patients With Ankylosing Spondylitis According to Uveitis Based on the Observation Study of Korean Spondyloarthropathy Registry (2020)
https://pubmed.ncbi.nlm.nih.gov/32637913/

Serum miR‐214 as a novel biomarker for ankylosing spondylitis (2019)
https://pubmed.ncbi.nlm.nih.gov/30729703/

miR-10b-5p is a novel Th17 regulator present in Th17 cells from ankylosing spondylitis (2017)
https://pubmed.ncbi.nlm.nih.gov/28039186/

Radiographic progression in patients with ankylosing spondylitis according to tumor necrosis factor blocker exposure: Observation Study of Korean Spondyloarthropathy Registry (OSKAR) data (2016)
https://pubmed.ncbi.nlm.nih.gov/26948670/

Comparison on radiographic progression for 5 years between juvenile onset ankylosing spondylitis and adult onset ankylosing spondylitis: an observational study of the Korean SpondyloArthropathy Registry (OSKAR) data (2016)
https://pubmed.ncbi.nlm.nih.gov/27051061/

Measuring impairments of functioning and health in patients with axial spondyloarthritis by using the ASAS Health Index and the Environmental Item Set: translation and cross-cultural adaptation into 15 languages (2016)
https://pubmed.ncbi.nlm.nih.gov/27752358/